MPM BioImpact - Crunchbase Company Profile & Funding

Q: Who invested in MPM BioImpact?

MPM BioImpact is funded by Meiji Seika Pharma.

Q: When was the last funding round for MPM BioImpact?

MPM BioImpact closed its last funding round on obfuscated from a Corporate Round round.

Q: How much funding has MPM BioImpact raised to date?

MPM BioImpact has raised obfuscated.

Overview

MPM BioImpact

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About MPM BioImpact

CB Rank

30021

MPM BioImpact is a biotechnology investment firm specializing in managing early-stage venture and private/public impact.

Founded

obfuscation

Private

Corporate Round

Boston, Massachusetts, United States

11-50

mpmbioimpact.com

Angel Investment

Biotechnology

Financial Services

Funding Rounds

Corporate Round

OBF

obfuscation

Key People

David Moskowitz: Principal
Past Role: Nuanced Health, Co-founding investor and Board Director

Details

Legal Name

MPM BioImpact, LLC.

Operating Status

Active

Number of Exits

obfuscation

Phone Number

+1 617 425 9200

Contact Email

info@mpmcapital.com

Predictions & Insights

Growth Insight

See this Growth Insight

MPM BioImpact is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

Orna Therapeutics

Develops circular RNA medicines using proprietary circular RNA platform and non-viral delivery technology for autoimmune diseases and oncology.

Aktis Oncology

Develops alpha radio-pharmaceuticals using miniprotein actinium-conjugates to treat solid tumors with improved safety and efficacy.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - MPM BioImpact	1	obfuscated obfuscation	Meiji Seika Pharma	Corporate Round
obfuscated obfuscation	Corporate Round - MPM BioImpact	1	obfuscated obfuscation	Meiji Seika Pharma	Corporate Round
obfuscated obfuscation	Corporate Round - MPM BioImpact	1	obfuscated obfuscation	Meiji Seika Pharma	Corporate Round
obfuscated obfuscation	Corporate Round - MPM BioImpact	1	obfuscated obfuscation	Meiji Seika Pharma	Corporate Round
obfuscated obfuscation	Corporate Round - MPM BioImpact	1	obfuscated obfuscation	Meiji Seika Pharma	Corporate Round

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - MPM BioImpact	1	obfuscated obfuscation	Meiji Seika Pharma	Corporate Round
obfuscated obfuscation	Corporate Round - MPM BioImpact	1	obfuscated obfuscation	Meiji Seika Pharma	Corporate Round
obfuscated obfuscation	Corporate Round - MPM BioImpact	1	obfuscated obfuscation	Meiji Seika Pharma	Corporate Round
obfuscated obfuscation	Corporate Round - MPM BioImpact	1	obfuscated obfuscation	Meiji Seika Pharma	Corporate Round
obfuscated obfuscation	Corporate Round - MPM BioImpact	1	obfuscated obfuscation	Meiji Seika Pharma	Corporate Round

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Meiji Seika Pharma	Yes	Corporate Round - MPM BioImpact	—
Meiji Seika Pharma	Yes	Corporate Round - MPM BioImpact	—
Meiji Seika Pharma	Yes	Corporate Round - MPM BioImpact	—
Meiji Seika Pharma	Yes	Corporate Round - MPM BioImpact	—
Meiji Seika Pharma	Yes	Corporate Round - MPM BioImpact	—

Investments

Investment Breakdown

Diversity Investments

Number of Investments

Number of Exits

obfuscation

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Adlai Nortye	—	Post-IPO Equity - Adlai Nortye	obfuscated obfuscation
obfuscated obfuscation	Adlai Nortye	—	Post-IPO Equity - Adlai Nortye	obfuscated obfuscation
obfuscated obfuscation	Adlai Nortye	—	Post-IPO Equity - Adlai Nortye	obfuscated obfuscation
obfuscated obfuscation	Adlai Nortye	—	Post-IPO Equity - Adlai Nortye	obfuscated obfuscation
obfuscated obfuscation	Adlai Nortye	—	Post-IPO Equity - Adlai Nortye	obfuscated obfuscation

Investment Breakdown

Number of Investments

Number of Exits

obfuscation

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Adlai Nortye	—	Post-IPO Equity - Adlai Nortye	obfuscated obfuscation
obfuscated obfuscation	Adlai Nortye	—	Post-IPO Equity - Adlai Nortye	obfuscated obfuscation
obfuscated obfuscation	Adlai Nortye	—	Post-IPO Equity - Adlai Nortye	obfuscated obfuscation
obfuscated obfuscation	Adlai Nortye	—	Post-IPO Equity - Adlai Nortye	obfuscated obfuscation
obfuscated obfuscation	Adlai Nortye	—	Post-IPO Equity - Adlai Nortye	obfuscated obfuscation

Diversity Investments

Number of Diversity Investments

Announced Date	Organization Name	Diversity Spotlight	Funding Round	Money Raised
obfuscated obfuscation	Crossbow Therapeutics	Women Founded	Series B - Crossbow Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Trevi Therapeutics	Women Founded, Women Led	Post-IPO Equity - Trevi Therapeutics	obfuscated obfuscation